Press release
Raltegravir Market Trends, Business Overview, Industry Growth and Forecast to 2028
The global raltegravir market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Raltegravir comes under a class of medications called HIV integrase inhibitors. It binds and inhibits integrase, an HIV enzyme that inserts viral genetic material into the genetic material of the infected human cell. Treatment of HIV is one of the key application area of raltegravir; therefore considerable increase in the prevalence of HIV is one of the major factors driving demand for raltegravir market. According to the data published by World Health Organization in 2021, HIV is a global public health issue that claimed 37.3 million lives. Further, as per the same source, approximately 37.7 million were living with HIV at the end of 2020, out of which one-third of the people belong to the African region. Moreover, in 2020, 68,00,00 mortalities occurred due to HIV-related causes and 1.5 million people acquired HIV.The high government intervention in form of government incentives, schemes, or funding is further promoting the growth of the global raltegravir market. For instance, in March 2021, Human Resources and Services Administration (HRSA) has awarded $99 million to expand access to HIV care, treatment, and support services under the "Ending the HIV Epidemic (EHE) " scheme. Moreover, the EHE initiative aims to reduce HIV infections in the US by 90.0% by 2030 and new HIV infections to less than 3000 annually. In addition, Health and Human Services(HHS) have awarded $117 million intending to end the HIV infections in the US, out of which $60 million is dedicated to linking people with HIV who are newly diagnosed. Thus, such initiatives are anticipated to create demand for raltegravir which in turn will drive the global market growth during the forecast period.
In addition, the market is currently experiencing several product innovations and advancement. For instance, in September 2021, ViiV Healthcare announced the exclusive license agreement with Shionogi to develop S-365598, a third-generation HIV integrase inhibitor with the potential for long-acting dosing intervals. Under the terms of the agreement, ViiV will make an upfront capital of $21 million to Shionogi, a $16 million payment for the achievement of clinical development, and royalties on net sales.
Moreover, ViiV Healthcare and Shionogi intend to initiate the first time in human studies with S-365598 by 2023.In addition, in July 2020, GlaxoSmithKline Plc has announced the approval of rukobia from the Us Food and Drug Administration (FDA). The drug in combination with other antiretrovirals is indicated to treat HIV-1 infection in heavily treatment-experienced adults with multi-drug resistant HIV-1 infection failing their current ARV regime due to resistance or intolerance.
In July 2021, Unitaid and Clinton Health Initiative, Inc has announced an agreement with Hetero. The agreement aimed to make darunavir coupled with ritonavir as an alternate therapy for HIV patients in low-income and middle-income countries. In June 2020, ViiV Healthcare has received US FDA approval for Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets to treat HIV-1 infection in pediatric patients atleast 4 weeks old and weighing at least 3kg in combination with other antiretroviral treatments.Thus, such approvals and collaborations are anticipated to accelerate the growth of the global raltegravir market during the forecast period.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Raltegravir Market at: https://orionmarketreports.com/request-sample/?id=92671&submit=Request+Sample%0D%0A
Market Coverage
•The market number available for - 2021-2028
•Base year- 2021
•Forecast period- 2022-2028
•Segment Covered-
•By Type
•By Distribution channel
•Regions Covered-
•North America
•Europe
•Asia-Pacific
•Rest of the World
Competitive Landscape- Merck & Co., Hetero Healthcare Ltd., and GlaxoSmithKline Plc among others.
A full report Raltegravir Market of is available at: https://orionmarketreports.com/raltegravir-market/92671/
Global Raltegravir Market Report by Segment
By Type
•Tablets
•Oral Powder
By Distribution Channel
•Hospital
•Drug Store
•Others
Key questions addressed by the report
•What is the market growth rate?
•Which segment and region dominate the market in the base year?
•Which segment and region will project the fastest growth in the market?
•How has COVID-19 impacted the market?
•Deviation from the pre-COVID-19 forecast
•Most affected region and segment
•Who is the leader in the market?
•How players are addressing challenges to sustain growth?
•Where is the investment opportunity?
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Raltegravir Market Trends, Business Overview, Industry Growth and Forecast to 2028 here
News-ID: 2586676 • Views: …
More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…

Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…

Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…

Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…